Kim JY - Search Results

1

Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).

Ko YG, Lee BK, Kang WC, Moon JY, Cho YH, Choi SH, Hong MK, Jang Y, Kim JY, Min PK, Kwon HM; PRINCIPLE Investigators. Ko YG, et al. Among authors: kim jy. Yonsei Med J. 2013 Jul;54(4):957-64. doi: 10.3349/ymj.2013.54.4.957. Yonsei Med J. 2013. PMID: 23709432 Free PMC article. Clinical Trial.

2

Magnitude of left atrial V wave is the determinant of exercise capacity in patients with mitral stenosis.

Park S, Ha JW, Ko YG, Kim J, Kang SM, Rim SJ, Jang Y, Chung N, Shim WH, Cho SY, Kim SS. Park S, et al. Am J Cardiol. 2004 Jul 15;94(2):243-5. doi: 10.1016/j.amjcard.2004.03.076. Am J Cardiol. 2004. PMID: 15246914

3

Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents.

Ko YG, Park S, Kim JY, Min PK, Choi EY, Jung JH, Joung B, Choi D, Jang Y, Shim WH. Ko YG, et al. Among authors: kim jy. Yonsei Med J. 2004 Aug 31;45(4):629-34. doi: 10.3349/ymj.2004.45.4.629. Yonsei Med J. 2004. PMID: 15344203 Free article. Clinical Trial.

4

Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?

Jung JH, Min PK, Kim JY, Park S, Choi EY, Ko YG, Choi D, Jang Y, Shim WH, Cho SY. Jung JH, et al. Among authors: kim jy. Cardiology. 2005;104(2):72-5. doi: 10.1159/000086688. Epub 2005 Jul 5. Cardiology. 2005. PMID: 16020923 Clinical Trial.

5

Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.

Kim JY, Ko YG, Shim CY, Park S, Hwang KC, Choi D, Jang Y, Chung N, Shim WH, Cho SY. Kim JY, et al. Am J Cardiol. 2005 Nov 15;96(10):1384-8. doi: 10.1016/j.amjcard.2005.07.042. Epub 2005 Sep 27. Am J Cardiol. 2005. PMID: 16275183

6

Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome.

Kim JY, Choi D, Guk Ko Y, Park S, Jang Y, Lee DY. Kim JY, et al. Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):571-5. doi: 10.1007/s00270-004-0165-7. Cardiovasc Intervent Radiol. 2006. PMID: 16502185

7

Systemic immunosuppressive therapy inhibits in-stent restenosis in patients with renal allograft.

Jung JH, Min PK, Kim JY, Park S, Choi EY, Ko YG, Choi D, Jang Y, Shim WH, Cho SY. Jung JH, et al. Among authors: kim jy. Catheter Cardiovasc Interv. 2006 Oct;68(4):567-73. doi: 10.1002/ccd.20799. Catheter Cardiovasc Interv. 2006. PMID: 16969853

8

Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.

Her AY, Kim JY, Kang SM, Choi D, Jang Y, Chung N, Manabe I, Lee SH. Her AY, et al. Among authors: kim jy. J Cardiovasc Pharmacol Ther. 2010 Jun;15(2):167-74. doi: 10.1177/1074248409357922. Epub 2010 Feb 10. J Cardiovasc Pharmacol Ther. 2010. PMID: 20147603 Clinical Trial.

9

Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease.

Kim JY, Mun HS, Lee BK, Yoon SB, Choi EY, Min PK, Yoon YW, Hong BK, Rim SJ, Kwon HM. Kim JY, et al. Yonsei Med J. 2010 Sep;51(5):676-82. doi: 10.3349/ymj.2010.51.5.676. Yonsei Med J. 2010. PMID: 20635441 Free PMC article.

10

Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg.

Wi J, Kim JY, Park S, Kang SM, Jang Y, Chung N, Shim WH, Cho SY, Lee SH. Wi J, et al. Among authors: kim jy. Atherosclerosis. 2010 Nov;213(1):235-40. doi: 10.1016/j.atherosclerosis.2010.08.068. Epub 2010 Sep 19. Atherosclerosis. 2010. PMID: 20855072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,717 results

Search Page

Filters